MDT vs SIBN
MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions. SIBN: SI-BONE provides specialized minimally invasive surgical systems designed to improve the lives of patients suffering from conditions of the spinopelvic anatomy.
Side-by-side fundamentals
| Metric | MDT | SIBN | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $93.03 | $20.82 | |
| Market cap | $119.0B | $933M | |
| P/E as of 2026-10-21 | 22.91 | n/a | |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2026 | 2.35 | n/a | |
| Net margin | +13.2% | -9.4% | MDT higher |
| Gross margin FY2025, SEC XBRL | n/a | +79.6% | |
| Operating margin | +17.8% | -11.1% | MDT higher |
| ROE | +9.7% | -10.6% | MDT higher |
| ROA | +5.2% | -7.9% | MDT higher |
| Debt / equity | 0.56 | 0.20 | SIBN lower |
| Revenue growth (YoY) | +8.4% | +20.2% | SIBN higher |
| Revenue CAGR (3y) SEC XBRL | +5.2% | +23.6% | SIBN higher |
| Dividend yield as of 2026-09-03 | +3.1% | n/a | |
| Dividend streak (yrs) SEC XBRL | 14 | 0 | MDT higher |
| Beta as of 2026-09-03 | 0.35 | 0.81 | |
| 1-year return as of 2026-10-21 close | -2.9% | +34.1% | SIBN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.